Suchen und filtern

Gefundene Studien

ACTICCA-2 Radiofrequency ablation via catheter and transpapillary access in patients with cholangiocarcinoma AIO-HEP-0323 · In Rekrutierung Studie anzeigen

TRAP-BTC Efficacy and safety of GemCis plus Trastuzumab plus Pembrolizumab in previously untreated HER2-positive biliary tract cancer AIO-HEP-0223/ass · In Rekrutierung Studie anzeigen

BATTALION Single-arm multicenter Phase II trial to investigate the efficacy of Botensilimab and Balstilimab in combination with gemcitabine/cisplatin for previously untreated patients with advanced or metastatic biliary tract cancer (BTC) AIO-HEP-0123 · In Vorbereitung Studie anzeigen

QS-Harnblase 2023 Qualitätssicherungsinitiative zur Therapie des Harnblasenkarzinoms in Deutschland 2023 AIO-URO-0123/ass · Rekrutierung beendet Studie anzeigen

TEAM-D Transsektorale MTB-Plattform Deutschland AIO-TF/YMO-0323 · In Rekrutierung Studie anzeigen

ALTERED KRAS Wild-Type Pancreatic Cancer Data Register AIO-PAK/YMO_0223 · In Vorbereitung Studie anzeigen

DISCUSS Discontinuation of CDK4/6 inhibitors in patients with metastatic HR positive, HER2 negative breast cancer with durable disease control: A randomized phase II trial of the AIO working groups breast cancer and quality of life AIO-MAM-LQ-0223 · In Rekrutierung Studie anzeigen

SAGA A phase Ib/II single-arm, multicenter study of sacituzumab-govitecan, a TROP-2 targeting antibody linked with SN38, for patients with metastatic esophagogastric adenocarcinoma AIO-STO-0123/ass · Rekrutierung beendet Studie anzeigen

mFOLFIRINOX-SBA Phase II randomized trial evaluating modified FOLFIRINOX and FOLFOX in the treatment of locally advanced or metastatic small bowel adenocarcinoma AIO-KRK/YMO-0423 · In Vorbereitung Studie anzeigen

SMARAGD Registerplattform Ovarial-/Endometriumkarzinom Clinical Research Platform on Ovarian, Fallopian Tube, Primary Peritoneal, and Endometrial Cancer Treatment and Outcomes AIO-MAM-0123/ass · In Rekrutierung Studie anzeigen